Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma

Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

NCT05572983 ·Status: RECRUITING ·Phase: PHASE2

Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

NCT04329130 ·Status: UNKNOWN ·Phase: PHASE2

Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

NCT05976997 ·Status: RECRUITING ·Phase: PHASE2

Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT03373019 ·Status: UNKNOWN ·Phase: PHASE2

SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma

NCT06122389 ·Status: RECRUITING ·Phase: PHASE3

Azacytidine Plus Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic T-cell Lymphoma

NCT05179213 ·Status: UNKNOWN ·Phase: PHASE2

Linperlisib Combined With Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

NCT07139353 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

NCT05958719 ·Status: RECRUITING ·Phase: PHASE2

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

NCT04512534 ·Status: RECRUITING ·Phase: PHASE2

Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients

NCT03023358 ·Status: UNKNOWN ·Phase: PHASE3

Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma

NCT06492629 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL).

NCT06550336 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase II Trail of Chidamide ,Rituximab and Methotrexate in Lymphoma Patients

NCT04516655 ·Status: UNKNOWN ·Phase: PHASE2

Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study

NCT04296786 ·Status: UNKNOWN ·Phase: PHASE2

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

NCT05690191 ·Status: ENROLLING_BY_INVITATION

Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

NCT04480125 ·Status: UNKNOWN ·Phase: PHASE2

Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

NCT06891157 ·Status: RECRUITING ·Phase: PHASE2

CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

NCT05896813 ·Status: UNKNOWN ·Phase: NA

A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma

NCT05495100 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

NCT03629873 ·Status: UNKNOWN ·Phase: PHASE2

Chidamide With PET Regimen for Angioimmunoblastic T Cell Lymphoma (PET: Prednisone, Etoposide and Thalidomide)

NCT03273452 ·Status: UNKNOWN ·Phase: PHASE2

Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)

NCT05772728 ·Status: UNKNOWN ·Phase: NA

Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma

NCT05348213 ·Status: RECRUITING ·Phase: PHASE2

A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy

NCT05527912 ·Status: UNKNOWN ·Phase: PHASE2

Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma

NCT03602131 ·Status: UNKNOWN ·Phase: PHASE2